Bioline Rx Ltd Geschätzer EPS Q/Q
Was ist das Geschätzer EPS Q/Q von Bioline Rx Ltd?
Geschätzer EPS Q/Q von Bioline Rx Ltd ist 0.00%
Was ist die Definition von Geschätzer EPS Q/Q?
Die voraussichtliche vierteljährliche EPS-Wachstumsrate im Jahresvergleich ist die geschätzte Steigerung des EPS eines Unternehmens für das nächste Quartal im Vergleich zur Leistung aus einem vergangenen entsprechenden Quartal.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Geschätzer EPS Q/Q von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Bioline Rx Ltd
Was macht Bioline Rx Ltd?
biolinerx is a clinical-stage, publicly-traded (nasdaq/ tase: blrx) biopharmaceutical development company based in modi'in, israel. this website or social media page (the “site”) of biolinerx ltd. (the “company”) may contain content posted by a third party or links to third party websites (the “content” or “third party content”). this content is provided solely for general informational purposes as a convenience to you and not as an endorsement by the company of the content. it does not constitute a recommendation or solicitation to purchase or sell any security or make any other type of investment or investment decision. the company is not responsible for this content and does not make any representations as to the subject matter, accuracy, completeness or timeliness or the content. if you decide to access linked third party websites, you do so at your own risk. there is no warranty of any kind, express or implied, regarding the content, including without limitation any warranty of m
Unternehmen mit geschätzer eps q/q ähnlich Bioline Rx Ltd
- Prestige Estates Projects hat Geschätzer EPS Q/Q von -0.40%
- Cigna hat Geschätzer EPS Q/Q von -0.35%
- Can Fin Homes hat Geschätzer EPS Q/Q von -0.33%
- Teleflex hat Geschätzer EPS Q/Q von -0.28%
- Ipca Laboratories hat Geschätzer EPS Q/Q von -0.24%
- Zebra Technologies hat Geschätzer EPS Q/Q von -0.22%
- Bioline Rx Ltd hat Geschätzer EPS Q/Q von 0.00%
- Teledyne Technologies Inc hat Geschätzer EPS Q/Q von 0.22%
- Universal Health Services hat Geschätzer EPS Q/Q von 0.34%
- Idexx Laboratories hat Geschätzer EPS Q/Q von 0.49%
- Discover Services hat Geschätzer EPS Q/Q von 0.55%
- United Parcel Service hat Geschätzer EPS Q/Q von 0.56%
- TMX hat Geschätzer EPS Q/Q von 0.56%